Chilton Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.51K | Buy |
+20
| New | +$2.51K | ﹤0.01% | 499 |
|
2022
Q3 | – | Sell |
-55
| Closed | -$11K | – | 251 |
|
2022
Q2 | $11K | Buy |
+55
| New | +$11K | ﹤0.01% | 449 |
|
2016
Q4 | – | Sell |
-6,763
| Closed | -$2.12M | – | 141 |
|
2016
Q3 | $2.12M | Sell |
6,763
-4,712
| -41% | -$1.47M | 0.21% | 87 |
|
2016
Q2 | $2.78M | Buy |
11,475
+172
| +2% | +$41.6K | 0.27% | 82 |
|
2016
Q1 | $2.94M | Sell |
11,303
-6,148
| -35% | -$1.6M | 0.29% | 83 |
|
2015
Q4 | $5.35M | Sell |
17,451
-20,260
| -54% | -$6.21M | 0.56% | 74 |
|
2015
Q3 | $11M | Buy |
37,711
+12,407
| +49% | +$3.62M | 1.13% | 33 |
|
2015
Q2 | $10.2M | Buy |
+25,304
| New | +$10.2M | 0.96% | 45 |
|